Comparison of nebulized glycopyrrolate and metaproterenol in chronic obstructive pulmonary disease

European Respiratory Journal

Volumn 9, Issue 1, 1996, Pages 100-103

  Tzelepis, G ^a,b   Komanapolli, S ^a   Tyler, D ^a   Vega, D ^a   Fulambarker, A ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Bronchitis; Bronchodilators; Glycopyrrolate

Indexed keywords

GLYCOPYRRONIUM BROMIDE; ORCIPRENALINE;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; SPIROMETRY;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; AGED; AGED, 80 AND OVER; BRONCHITIS; BRONCHODILATOR AGENTS; CHRONIC DISEASE; DRUG COMBINATIONS; DRUG INTERACTIONS; FORCED EXPIRATORY VOLUME; GLYCOPYRROLATE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; ORCIPRENALINE; PULMONARY EMPHYSEMA;

EID: 0030030784     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09010100     Document Type: Article

References (22)

1. Gal TJ, Suratt PM, Lu JY. Glycopyrrolate and atropine inhalation: comparative effects on normal airway function. Am Rev Respir Dis 1984; 129: 871-873.
2. Gilman MJ, Meyer L, Carter J, Slovis C. Comparison of aerosolized glycopyrrolate and metaproterenol in acute asthma. Chest 1990; 98: 1095-1098.
3. Walker FB, Kaiser DL, Kowal MB, Suratt PM. Prolonged effect of inhaled glycopyrrolate in asthma. Chest 1987; 91: 49-51.
4. Johnson BE, Suratt PM, Gal TJ, Wilhoit SC. Effect of inhaled glycopyrrolate and atropine in asthma. Chest 1984; 85: 325-328.
5. Schroeckestein DC, Bush RK, Chervinsky P, Busse WW. Twelve hour bronchodilation in asthma with a single aerosol dose of the anticholinergic compound glycopyrrolate. J Allergy Clin Immunol 1988; 82: 115-119.
6. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
7. Dixon WJ (Ed.). BMDP statistical software manual. Berkeley, CA, University of California Press, 1990; Vol. 2.
8. Komanapolli S, Fulambarker A, Tyler D, Vega D, Patel J, Tzelepis G. Effects of glycopyrrolate and metaproterenol alone and in combination in COPD. Am Rev Respir Dis 1993; 147 (4): A316 (Abstract).
9. Dougals NJ, Davidson I, Sudlow MF, Fleney D. Bronchodilatation and the site of airway resistance in severe chronic bronchitis. Thorax 1979; 34: 51-56.
10. Lightbody LM, Ingram CG, Legge JS, Johnston RN. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis. Br J Dis Chest 1978; 72: 181-186.
11. Koyama H, Nishimura K, Ikeda A, Izumi T. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease. Chest 1993; 104: 1743-1747.
12. Less AW, Allan GW, Smith J. Nebulized ipratropium bromide and salbutamol in chronic bronchitis. Br J Clin Pract 1980; 3: 340-342.
13. Leitch AG, Hopkin JM, Ellis DA, Merchant S, McHardy GJR. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax 1978; 33: 711-713.
14. Petrie GR, Palmer KNV. Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma. Br Med J 1975; 1: 430-432.
15. Combivent Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. Chest 1994; 105: 1411-1419.
16. Rebuck AS, Chapman KR, Abboud R, Paré PD, Kreisman H, Wolkove N. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airway disease in the emergency room. Am J Med 1987; 82: 59-64.
17. Karpel JP, Pesin J, Greenberg D, Gentry E. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. Chest 1990; 98: 835-839.
18. Karpel JP. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD. Chest 1991; 99: 871-876.
19. Lloberes P, Ramis L, Montserrat JM, et al. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. Eur Respir J 1988; 1: 536-539.
20. Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med 1984; 311: 421-425.
21. 2-adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in combination. N Engl J Med 1986; 315: 753-759.
22. Marini JJ, Lakshminarayan S. The effect of atropine inhalation in "irreversible" chronic bronchitis. Chest 1980; 77: 591-596.